LakeShore Biopharma Risk Adjusted Performance
| LSBDelisted Stock | | | 0.63 0.00 0.00% |
The Risk Adjusted Performance lookup presents technical context for LakeShore Biopharma Co and related instruments. Coverage varies by data normalization and availability; see
Equity Screeners for broader screening context. LakeShore Biopharma has a market cap of 25.84 M, operating margin of -68.83%, ROE of -18.43%.
Correlation Analysis can help frame allocation decisions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in main economic indicators.
LakeShore Biopharma Co has current Risk Adjusted Performance of 0.0243.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | 0.0243 | |
LakeShore Biopharma Risk Adjusted Performance Peers Comparison
LakeShore Risk Adjusted Performance Relative To Other Indicators
LakeShore Biopharma Co is rated
fifth in risk adjusted performance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
3,785 of Maximum Drawdown per Risk Adjusted Performance. At
3,785 , LakeShore Biopharma Co's Maximum Drawdown-to-Risk Adjusted Performance multiple reflects the spread between these metrics
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.